If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMurray Income Trust Regulatory News (MUT)

Share Price Information for Murray Income Trust (MUT)

Share Price is delayed by 15 minutes
Get Live Data
992.00    -4.00 (-0.40%)
Bid:
992.00
Ask:
993.00
Spread: 1.00 (0.101%)
Market Cap: £925.67m
MUT Live PriceLast checked at - London Stock Exchange

Intraday Murray Income Trust Share Chart

Reduction in Management Fee

30 Aug 2024 07:00

RNS Number : 2060C
Murray Income Trust PLC
30 August 2024
 

MURRAY INCOME TRUST PLC

Legal Entity Identifier (LEI): 549300IRNFGVQIQHUI13

 

30 August 2024

 

Reduction in Management Fee

Murray Income Trust PLC (the "Company") announces that it has reduced and simplified its investment management fee arrangements with abrdn Fund Managers Limited (the "Manager").

With effect from 1 July 2024, the annual investment management fee is calculated as 0.35% of the Company's net assets up to £1.1 billion and 0.25% of any net assets above £1.1 billion. Formerly, the fee was 0.55% on the first £350 million of net assets, 0.45% on net assets from £350 million to £450 million and 0.25% on any net assets in excess of £450 million.

Peter Tait, Chair, commented:

"I am very pleased to announce that the Board of Murray Income Trust PLC has come to an agreement with the Manager for a revised fee schedule to be applied from the beginning of the Company's current financial year, 1 July 2024. The headline fee rate will now be 0.35% on the first £1.1 billion of net assets in the portfolio. We believe that this is a competitive fee in the universe of UK equity income funds and should prove attractive to both existing and potential shareholders."

Enquiries:

For further information, please contact:

Stuart Reid

abrdn Holdings Limited

Secretaries

Email:  cef.cosec@abrdn.com

 

About the Company

 

Murray Income Trust PLC, established in 1923, is an investment trust aiming for high and growing income with capital growth through investment in a portfolio principally composed of UK equities. Managed by abrdn, a leading global asset management company, the Company has a market cap approaching £1 billion, is listed on the London Stock Exchange and is a constituent of the FTSE-250 Index.

 

The Company is recognised as a 'Dividend Hero' by the Association of Investment Companies, boasting a 51-year track record of annual dividend increases, making it an attractive choice for risk-averse income seekers. The Manager's investment process prioritises quality characteristics, targeting exceptional companies by thoroughly evaluating their management, finances, and business models first-hand. This rigorous approach aims to build a portfolio capable of delivering a high and growing income, with dividends paid quarterly.

 

The Manager employs a '3D' investment approach - dependable, diversified, and differentiated - to identify high-quality large-cap companies with robust earnings potential, as well as small and mid-cap companies with strong growth prospects. The ability to invest up to 20% of the portfolio in overseas-listed companies provides differentiation from peers.

 

The Board of the Company and the Manager believe that investment in the UK equity income sector offers a compelling opportunity, with investors increasingly recognising that dividends are a key driver of long-term total equity returns. Many areas of the UK market have seen dividends rebased and pay-out ratios remain modest, providing a strong foundation for dividend growth. The Manager's focus on quality companies gives investors access to predominantly global businesses capable of delivering appealing long-term earnings and dividend growth.

 

For more information, or to sign up for regular updates from the Company, please visit: www.murray-income.co.uk.

 

END

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGZRDLKGDZM
Date   Source Headline
6th Mar 20263:09 pmRNSMonth End Net Asset Value(s)
6th Mar 202612:52 pmRNSNet Asset Value(s)
5th Mar 202611:50 amRNSNet Asset Value(s)
5th Mar 202611:37 amRNSDirector/PDMR Shareholding
4th Mar 20261:03 pmRNSNet Asset Value(s)
3rd Mar 20262:12 pmRNSNet Asset Value(s)
2nd Mar 20267:01 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSAppointment of Investment Manager & Secretary
27th Feb 202612:26 pmRNSNet Asset Value(s)
27th Feb 20267:00 amRNSHalf-year Financial Report
26th Feb 202612:25 pmRNSNet Asset Value(s)
25th Feb 202612:08 pmRNSNet Asset Value(s)
24th Feb 202611:57 amRNSNet Asset Value(s)
23rd Feb 202612:39 pmRNSGearing disclosure
23rd Feb 202612:05 pmRNSNet Asset Value(s)
20th Feb 202611:18 amRNSNet Asset Value(s)
19th Feb 202612:22 pmRNSNet Asset Value(s)
18th Feb 20265:07 pmRNSTransaction in Own Shares
18th Feb 202611:00 amRNSNet Asset Value(s)
17th Feb 202610:32 amRNSNet Asset Value(s)
16th Feb 20265:07 pmRNSTransaction in Own Shares
16th Feb 20261:40 pmRNSGearing disclosure
16th Feb 202612:20 pmRNSNet Asset Value(s)
16th Feb 20269:40 amRNSPortfolio disclosure
13th Feb 202612:39 pmRNSNet Asset Value(s)
12th Feb 20265:10 pmRNSTransaction in Own Shares
12th Feb 202611:01 amRNSNet Asset Value(s)
11th Feb 20265:06 pmRNSTransaction in Own Shares
11th Feb 202612:22 pmRNSNet Asset Value(s)
10th Feb 20265:22 pmRNSTransaction in Own Shares
10th Feb 202612:14 pmRNSNet Asset Value(s)
9th Feb 20262:44 pmRNSGearing disclosure
9th Feb 20261:16 pmRNSNet Asset Value(s)
6th Feb 202611:20 amRNSNet Asset Value(s)
5th Feb 20265:11 pmRNSTransaction in Own Shares
5th Feb 20262:00 pmRNSMonth End Net Asset Value(s)
5th Feb 202610:46 amRNSNet Asset Value(s)
4th Feb 20265:05 pmRNSTransaction in Own Shares
4th Feb 202611:05 amRNSNet Asset Value(s)
3rd Feb 202612:45 pmRNSNet Asset Value(s)
2nd Feb 20264:11 pmRNSGearing disclosure
2nd Feb 202610:12 amRNSTotal Voting Rights
30th Jan 202612:19 pmRNSNet Asset Value(s)
29th Jan 202612:19 pmRNSNet Asset Value(s)
28th Jan 202611:35 amRNSNet Asset Value(s)
28th Jan 20267:00 amRNSManager transition update and shareholder webinar
27th Jan 202611:46 amRNSNet Asset Value(s)
26th Jan 20262:37 pmRNSGearing disclosure
26th Jan 202612:25 pmRNSNet Asset Value(s)
23rd Jan 20265:09 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.